Treatment with leuprolide acetate and hormonal add-back for up to 10 years in stage IV endometriosis patients with chronic pelvic pain
This study investigated the long-term efficacy and safety of leuprolide acetate with hormonal add-back therapy for managing chronic pelvic pain in patients with stage IV endometriosis over a 10-year period.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
My notes (saved in your browser only)
Condition tags
MeSH descriptors
Citation neighborhood
Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.
References (15)
- GnRH agonists and add‐back therapy: is there a perfect combination? via openalex
- Gonadotropin-releasing hormone agonists and estrogen-progestogen replacement therapy via openalex
- Historical prospective cohort study of the recurrence of pain after discontinuation of treatment with danazol or a gonadotropin- releasing hormone agonist via openalex
- Prevalence and genesis of endometriosis via openalex
- Prevention of bone loss and hypoestrogenic symptoms by estrogen and interrupted progestogen add-back in long-term GnRH-agonist down-regulated patients with endometriosis and premenstrual syndrome via openalex
- Spontaneous reversibility of bone loss induced by gonadotropin-releasing hormone analog treatment via openalex
- Spontaneous reversibility of bone loss induced by gonadotropin-releasing hormone analog treatment. via openalex
- W133578770 via openalex
- W6683236057 via openalex
- W1593442063 via openalex
- W1974638277 via openalex
- W1990697327 via openalex
- W2159608759 via openalex
- W2337521034 via openalex
- W2398404805 via openalex
Cited by (50)
- Endometriosis-Associated Infertility: A Review of Pathophysiological Mechanisms and Current Treatment Strategies 2026
- Lignes directrices de pratique clinique n° 468 : Prise en charge clinique de l'endométriose 2026
- Pathogenetic therapy of endometriosis: Updated data on the use of buserelin acetate (depot form) 2025
- Experience of using drospirenone/ethinyl estradiol combination in women of reproductive age 2024
- Treatment of Adolescent Endometriosis Before, During, and After Use of Gonadotropin-Releasing Hormone Agonists: A Retrospective Cohort Study 2023
- Agonists of gonadotropin-releasing-hormone and add-back-therapy 2023
- Advances in targeting estrogen synthesis and receptors in patients with endometriosis 2022
- Medical Management of Endometriosis in Adolescents 2020
- Diagnostik und Therapie der Endometriose gemäß S2k-Leitlinie 2020
- Medical treatment of endometriosis: is it a choice of the physician? 2020
- Endometriosis 2019
- Chapitre 3 : Prise en charge médicale de la douleur associée à l'endométriose 2019
- Tratamientos farmacológicos de la endometriosis (a excepción de la adenomiosis) 2018
- Diagnostik und Therapie der Endometriose nach der S2k-Leitlinie 2017
- Long-term medical management of endometriosis with dienogest and with a gonadotropin-releasing hormone agonist and add-back hormone therapy 2017
- An Interdisciplinary Approach to Endometriosis-associated Persistent Pelvic Pain 2017
- Office management of pelvic pain and dyspareunia 2016
- Gynecology 2016
- Low-dose add-back therapy during postoperative GnRH agonist treatment 2016
- Our experience with long-term triptorelin therapy in a large endometriosis nodule arising in an episiotomy scar 2015
- Long-term follow-up of bone density in women with primary ovarian insufficiency 2015
- Treatment of pain associated with deep endometriosis: alternatives and evidence 2015
- Medical Treatment of Ureteral Obstruction Associated With Ovarian Remnants and/or Endometriosis: Report of Three Cases and Review of the Literature 2014
- Endometriosis 2014
- Systemische Therapie der Endometriose: Alternativen zur Hormontherapie 2014
- Triptorelin for the treatment of endometriosis 2014
- Medikamentöse Therapie der Endometriose 2014
- Menstrual Problems for the MRCOG and Beyond 2014
- Endometriosis for the primary care physician 2013
- Endometriosis 2013
- Medikamentöse Therapie der Endometriose 2013
- Oral continuous combined 0.5 mg estradiol valerate and 5 mg dydrogesterone as daily add-back therapy during post-operative GnRH agonist treatment for endometriosis in Chinese women. 2013
- Hormonal strategy for the primary or secondary treatment of endometriosis 2012
- Elevated immunoreactivity of RANTES and CCR1 correlate with the severity of stages and dysmenorrhea in women with deep infiltrating endometriosis 2012
- Traitement médical de l’endométriose : pas une simple option, mais une obligation ! 2012
- Medical Treatment in Endometriosis 2012
- Markers of Adult Endometriosis Detectable in Adolescence 2011
- Evidence-based long-term management of endometriosis: Medical therapy and treatment of infertility 2011
- Helping “Adult Gynecologists” Diagnose and Treat Adolescent Endometriosis: Reflections on My 20 Years of Personal Experience 2011
- Endometriosis: The Role of Neuroangiogenesis 2011
- Medikamentöse Therapie der chronischen Endometriose 2011
- Endometriosis: Diagnosis and Management 2010
- Medical Management of Pain Associated With Endometriosis 2010
- Optimal management of chronic cyclical pelvic pain: an evidence-based and pragmatic approach 2010
- Chronische Endometriose: medikamentöse Therapie 2010
- Postmenopausal Endometriosis 2010
- Endometriosis 2009
- Chronic pelvic pain in women 2009
- Immediate and delayed add‐back hormonal replacement therapy during ultra long GnRH agonist treatment of chronic cyclical pelvic pain 2009
- Endometriosis 2009
Source provenance
- europepmc
- last seen: 2026-06-04T01:30:01.192114+00:00
- openalex
- last seen: 2026-06-04T00:00:01.174412+00:00
- pubmed
- last seen: 2026-05-13T22:15:18.313808+00:00